R
Rubius Therapeutics
Focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases through its rubius erythrocyte design cellular therapy platform
About Rubius Therapeutics
Rubius Therapeutics is a biotechnology company focused on developing innovative cellular therapies by transforming red blood cells into medicines. The company primarily serves patients with cancer and autoimmune diseases, aiming to provide life-changing treatments. Operating in the biopharmaceutical market, Rubius Therapeutics leverages its deep scientific expertise and dedicated team to advance its pipeline of promising drug candidates. The business model revolves around the research, development, and commercialization of these cellular therapies. Revenue is generated through the successful development and sale of these therapies, as well as potential partnerships and collaborations with other pharmaceutical companies.
Source: Dealroom company dataAt a glance
- Founded
- 2013
- Headquarters
- Cambridge, United States
- Listing
- IPO 2018
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tier
Latest news
Press, funding announcements and product moves mentioning Rubius Therapeutics.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Series B and later2 investors entered at this stage
- MTMassachusetts Institute of Technology
- WIWhitehead Institute
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
11 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Rubius Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Rubius Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.